Elidel and Walking disability - a phase IV clinical study of FDA data
We study 6,707 people who take Elidel or have Walking disability. No report of Walking disability is found in people who take Elidel.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Elidel?
Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 4,405 Elidel users for its effectiveness, alternative drugs and more.
What is Walking Disability?
Walking disability is found to be associated with 1,002 drugs and 714 conditions by eHealthMe.
Do you take Elidel and have Walking disability?Check whether Walking disability is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Walking disability and when was it recovered:
Expand to all the drugs that have ingredients of pimecrolimus:
Alternative drugs to, pros and cons of Elidel:
- Elidel (4,405 reports)
Walking disability treatments and more:
- Walking disability (2,302 reports)
COVID vaccines that are related to Walking disability:
- Walking disability in Moderna COVID Vaccine
- Walking disability in Pfizer BioNTech Covid Vaccine
- Walking disability in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Walking disability:
All the conditions that are associated with Walking disability:
How the study uses the data?
The study uses data from the FDA. It is based on pimecrolimus (the active ingredients of Elidel) and Elidel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Venastat and Stools - Watery - 3 seconds ago
- Venastat and Diarrhea - 3 seconds ago
- Ropinirole Hydrochloride and Memory Loss - 3 seconds ago
- Flonase vs. Chlorpheniramine Maleate - 5 seconds ago
- Elavil and Osteopenia - 8 seconds ago
- Voriconazole and Bupropion Hydrochloride drug interaction - 9 seconds ago
- Ibu and Atypical Mycobacterium Test Positive - 11 seconds ago
- Tigan and Weight Increased - 11 seconds ago
- Plendil and Polyp - 12 seconds ago
- Buprenorphine Hydrochloride vs. Clonidine Hydrochloride - 14 seconds ago